Comments
Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Quinapril tablets.
Quinapril tablets is the generic equivalent of Pfizer Pharmaceuticals Ltd’s Accupril tablets and are indicated for the treatment of hypertension, the Hyderabad-based company said in a release.
The market size of the product was estimated to be $49 million for the 12 months ending September 2012, according to IMS.
The product was approved out of the Unit VII (SEZ) formulations facility in Hyderabad.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.